ArticleJournal of personalized medicine2022

Ribosomal DNA Abundance in the Patient's Genome as a Feasible Marker in Differential Diagnostics of Autism and Childhood-Onset Schizophrenia.

Elizaveta S Ershova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.